Literature DB >> 26306786

Apolipoprotein E-ε4 deficiency and cognitive function in hepatitis C virus-infected patients.

M A Wozniak1, L M Lugo Iparraguirre2, M Dirks2, M Deb-Chatterji2, H Pflugrad2, A Goldbecker2, A B Tryc2, H Worthmann2, M Gess3, M M E Crossey4, D M Forton3, S D Taylor-Robinson4, R F Itzhaki1, K Weissenborn2.   

Abstract

Hepatitis C virus (HCV) causes not only liver damage in certain patients but can also lead to neuropsychiatric symptoms. Previous studies have shown that the type 4 allele of the gene for apolipoprotein E (APOE) is strongly protective against HCV-induced damage in liver. In this study, we have investigated the possibility that APOE genotype is involved in the action of HCV in brain. One hundred HCV-infected patients with mild liver disease underwent a neurological examination and a comprehensive psychometric testing of attention and memory function. In addition, patients completed questionnaires for the assessment of fatigue, health-related quality of life and mood disturbances. Apolipoprotein E gene genotyping was carried out on saliva using buccal swabs. The APOE-ε4 allele frequency was significantly lower in patients with an impairment of working memory, compared to those with a normal working memory test result (P = 0.003). A lower APOE-ε4 allele frequency was also observed in patients with definitely altered attention ability (P = 0.008), but here, the P-value missed the level of significance after application of the Bonferroni correction. Our data suggest that the APOE-ε4 allele is protective against attention deficit and especially against poor working memory in HCV-infected subjects with mild liver disease. Considering the role of apolipoprotein E in the life cycle of the virus, the findings shed interesting new light upon possible pathomechanisms behind the development of neuropsychiatric symptoms in hepatitis C infection.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  attention; cerebral lipoprotein metabolism; hepatitis C virus encephalopathy; neurodegeneration; virus replication

Mesh:

Substances:

Year:  2015        PMID: 26306786     DOI: 10.1111/jvh.12443

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  5 in total

Review 1.  Neuroimaging Findings in Chronic Hepatitis C Virus Infection: Correlation with Neurocognitive and Neuropsychiatric Manifestations.

Authors:  Matteo Tagliapietra; Salvatore Monaco
Journal:  Int J Mol Sci       Date:  2020-04-02       Impact factor: 5.923

2.  Apolipoprotein E polymorphism influences orthotopic liver transplantation outcomes in patients with hepatitis C virus-induced liver cirrhosis.

Authors:  José Carlos Rodrigues Nascimento; Lianna C Pereira; Juliana Magalhães C Rêgo; Ronaldo P Dias; Paulo Goberlânio B Silva; Silvio Alencar C Sobrinho; Gustavo R Coelho; Ivelise Regina C Brasil; Edmilson F Oliveira-Filho; James S Owen; Pierluigi Toniutto; Reinaldo B Oriá
Journal:  World J Gastroenterol       Date:  2021-03-21       Impact factor: 5.742

3.  Lack of Causal Relationships Between Chronic Hepatitis C Virus Infection and Alzheimer's Disease.

Authors:  Lin Huang; Yongheng Wang; Yaqin Tang; Yijie He; Zhijie Han
Journal:  Front Genet       Date:  2022-03-10       Impact factor: 4.599

4.  Risk Factors for Severe COVID-19 and Hepatitis C Infections: The Dual Role of Apolipoprotein E4.

Authors:  Felipe B Lima; Karine C Bezerra; José Carlos R Nascimento; Gdayllon C Meneses; Reinaldo B Oriá
Journal:  Front Immunol       Date:  2022-03-11       Impact factor: 7.561

5.  APOE ϵ4 modifies the relationship between infectious burden and poor cognition.

Authors:  Chen Zhao; Kevin Strobino; Yeseon Park Moon; Ying Kuen Cheung; Ralph L Sacco; Yaakov Stern; Mitchell S V Elkind
Journal:  Neurol Genet       Date:  2020-07-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.